Strategic Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,501
| Closed | -$227K | – | 205 |
|
|
2024
Q1 | $227K | Sell |
3,501
-99
| -3% | -$6.41K | 0.04% | 187 |
|
|
2023
Q4 | $237K | Sell |
3,600
-522
| -13% | -$34.4K | 0.04% | 183 |
|
|
2023
Q3 | $235K | Hold |
4,122
| – | – | 0.05% | 180 |
|
|
2023
Q2 | $253K | Buy |
4,122
+15
| +0.4% | +$919 | 0.05% | 172 |
|
|
2023
Q1 | $258K | Buy |
+4,107
| New | +$258K | 0.05% | 177 |
|